Pag-aaral pangklinika para sa COPD sa Missouri
10 pag-aaral para sa COPD ang naghahanap ng mga kalahok sa mga site sa Missouri.
Mga Lungsod sa Missouri
Opisyal na teksto ng pag-aaral (English)
Rademikibart IV for Acute Asthma and COPD Exacerbation
- Washington University- Cardiovascular Imaging and Clinical Research Core Laboratory, St Louis
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07705737To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Hannibal Regional Healthcare System, Inc., Hannibal
Nagre-recruitPhase 2
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chesterfield
- Research Site, Hannibal
- Research Site, St Louis
- at 1 pa
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Hannibal Regional Healthcare System- Site Number : 8400035, Hannibal
- Washington University- Site Number : 8400144, St Louis
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Washington University School of Medicine, St Louis
- Barnes-Jewish Hospital Investigational Drug Service, St Louis
- Barnes-Jewish Hospital, St Louis
- at 2 pa
Nagre-recruitPhase 2/3
Edad 35 hanggang 80 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07363694A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Hannibal
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, St Louis
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, St Louis
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06283966Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Midwest Chest Consultants, P.C., Saint Charles
Nagre-recruitPhase 4
Edad 60 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07816835A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, St Louis
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06883305Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.